Philippine Tourism Has Three Arrival Counters and a 300,000 Gap
CIMC Group Announces Results for the First Three Quarters of 2026
U.S. Polo Assn. Executes Early on Europe’s Digital Product Passport Mandate
COSCO SHIPPING Ports Announces 2026 Third Quarter Results
Beyond the Hype: Singapore’s Aivo Asia Scales Unified SaaS Platform to Drive Real Business Growth Through Conversational AI
Lead product candidate, ZB001, has first-in-class potential in China for Thyroid Eye Disease Rapidly advancing…
— Collaboration expected to accelerate access to Evelo’s lead inflammation product candidate and COVID-19 therapeutic…
For the First Time Scientific Data From a Certified Canadian Laboratory Answers This Fundamental Question….
Press Release Nicox’s NCX 470 Mont Blanc Phase 3 Glaucoma Trial Reaches 50% Enrollment Milestone…
Phase III VISION study with 177Lu-PSMA-617 met both primary endpoints, significantly improving overall survival (OS)…
With eight new configurations, cobas pro® integrated solutions offers labs greater flexibility to ramp up…
Investigational antibody cocktail of casirivimab and imdevimab also significantly shortened the duration of symptoms by…
WEST CHESTER, Pa., March 22, 2021 (GLOBE NEWSWIRE) — Verrica Pharmaceuticals Inc. (Verrica) (NASDAQ: VRCA),…
Expanding existing COVID-19 vaccine research collaboration which began in July 2020. Medytox and Dyadic to…
NEW HAVEN, Conn., March 22, 2021 (GLOBE NEWSWIRE) — BIOASIS TECHNOLOGIES INC. (TSXV:BTI; OTCQB:BIOAF), (the…
Company announcement – No. 16 / 2021 Zealand Pharma Announces FDA Approval of Zegalogue® (dasiglucagon)…
Bagsværd, Denmark, 22 March 2021 – Novo Nordisk today announced that the US Food and…
Blood Sugar Blaster is a sugar-regulating supplement that seeks to prevent the user from catching…
EDISON, N.J., March 22, 2021 (GLOBE NEWSWIRE) — Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA, “Hepion”), a clinical…
– Phase 2 RUN-HN trial showed ORR of 55%, median PFS of 5.6 months and…
CHARLESTON, S.C., March 22, 2021 (GLOBE NEWSWIRE) — Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS)…
FOSTER CITY, Calif., March 22, 2021 (GLOBE NEWSWIRE) — Vaxcyte, Inc. (Nasdaq: PCVX), a next-generation…
YONKERS, N.Y., March 22, 2021 (GLOBE NEWSWIRE) — ContraFect Corporation (Nasdaq: CFRX), a clinical-stage biotechnology…
WEST CHESTER, Pa., March 22, 2021 (GLOBE NEWSWIRE) — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA), a dermatology…
SANTA MONICA, Calif., March 22, 2021 (GLOBE NEWSWIRE) — Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT), a…